ALISHA LEE: Open Payments
NPI 1902184930 · TYLER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,083 in 65 payments from 6 companies in 2025. Trend: 2023 $414 · 2024 $732 · 2025 $1,083
Food & beverage: $1,083
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 23 | $367 |
| ABBVIE INC. | 23 | $311 |
| Gilead Sciences, Inc. | 13 | $300 |
| GENZYME CORPORATION | 3 | $76 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 2 | $13 |
Products named: REZDIFFRA, RINVOQ, DUPIXENT, SKYRIZI, EPKINLY, MAVYRET, CREON, IMBRUVICA.
Industry payments across TX — which companies pay providers there.
